Background: Radiofrequency catheter ablation (CA) is an effective treatment of drug-refractory atrial fibrillation (AF). However, the efficacy of CA by race and gender has not been well characterized. We sought to determine the impact of ethnicity and gender on clinical outcome following CA in patients with AF.
INTRODUCTION
There is a high prevalence of atrial fibrillation (AF) in both genders and across all ethnicities. 1 AF is increasingly common with advanced age and associated with significant morbidity and mortality. [1] [2] [3] [4] [5] Genderbased differences in presentation of AF have been reported as the incidence of AF is lower in women. Heart failure and underlying valvular heart disease are more common in women, while men more often have AF associated with coronary artery disease (CAD). Overall, women with AF are older and have lower quality of life, more symptoms, and more significant comorbidities compared with men. 6 Similarly, there are race-based differences in presentation and characteristics of AF. It is reported that black patients have less AF despite more traditional risk factors and that European ancestry is associated with greater AF risk. [7] [8] [9] Blacks with AF have been shown to have higher incidence of stroke, heart failure, CAD, and even sudden cardiac death than whites. [10] [11] [12] However, impact of race and gender on overall clinical outcome and efficacy of catheter ablation (CA) for the treatment of AF have not been well documented.
Pulmonary vein isolation by CA has been demonstrated to be an effective treatment to restore and maintain normal sinus rhythm in patients with AF. [13] [14] [15] Women with AF, however, are generally treated less aggressively with fewer cardioversions and CA. [16] [17] [18] Recent studies have differed in answering whether women have similar or higher long-term AF recurrence rates after CA, with the matter yet to be definitively settled. 19, 20 There is also evidence of higher postprocedure complication rates in women, such as increased rates of cardiac tamponade. 21 Further, there is a significant racial disparity in use of CA as a treatment modality in patients with AF. Compared to whites, black and Hispanic patients have a lower rate of CA when hospitalized for AF. [16] [17] [18] These race and gender differences persist despite correcting for age, medical comorbidities, and income. Notably, prior studies have shown nearly equal use of CA with respect to race in the management of other arrhythmias, such as atrial flutter. 22 One factor possibly accounting for these differences is that clinical outcomes following CA in patients with AF have not been well demonstrated by ethnicity and gender.
Thus, we aimed to determine the impact of gender, ethnicity, and gender-specific ethnicity on early and late recurrence of AF following first CA for AF. All patients who underwent single CA procedure for paroxysmal and persistent AF in our institution were included in analysis to characterize the gender-and ethnicity-based disparity, investigate the clinical outcome, and evaluate predictors for differences.
METHODS

Study population
All patients who underwent catheter-based pulmonary vein isolation for AF between October 2013 and April 2016 at the University of Chicago were included in this study. The study cohort included patients with only single CA procedure for paroxysmal and persistent AF. Those patients who had previously undergone CA for AF before the study dates were excluded. Patients were identified retrospectively and followed prospectively. Patients lost to follow-up or with no demographic information provided were also removed from the study cohort. The study was approved by the Institutional Review Board.
Data collection
Data were collected from a centralized system electronic medical record that contained complete records of all patients treated and followed at the University of Chicago during the range of study dates.
These records contain detailed histories and diagnoses for all inpatient and outpatient encounters including emergency room visits, diagnostic tests, and clinical follow-up. Charts were reviewed for baseline characteristics including demographic information, medical history, electrocardiogram (ECG), Holter recording, echocardiogram, event monitor, and procedural details.
Follow-up
The follow-up period for the patients who underwent ablation began at the time of the procedure and ended on July 2016. Patients had clinic visits within one month of the procedure, and at regular 3-to 6-month intervals thereafter. ECG and symptom assessment were performed in all patients during those follow-up visits. Holter recording was performed if symptoms were suggestive of recurrence but this was not captured on ECG. Early recurrence was defined as AF detected within 3 months of ablation, while late recurrence was defined as AF detected between 3 months postablation and most recent follow-up.
CA
All patients underwent standard CA using radiofrequency energy for pulmonary vein isolation. 1,6,14 CA was performed using an endpoint of entrance and exit block. Additional ablation such as roof line or mitral isthmus line was performed in a minority of patients (7.6%) and was based on patient-specific conditions and operator. 
Statistical analysis
RESULTS
Demographic characteristics
A total of 118 patients (79 men and 39 women) were included in this study. All patients underwent first-time CA for pulmonary vein isolation during the study period. Overall, 93 patients (78.8%) were white, 18 patients (15.3%) were black, two patients (2%) were Hispanic, three patients (3%) were Asian/Pacific Islander, and two patients (2%) were of mixed race. Mean follow-up after CA was 18.2 ± 8 months (median 18.2 months, range 3.4-34.5 months) in the total cohort.
Approximately two-thirds of the patients had paroxysmal AF while one-third had persistent AF. The baseline characteristics of the entire study cohort and as stratified by race and gender are summarized in Table 1 .
There were several race-and gender-based differences in the baseline characteristics of the cohort. Women had significantly more thyroid dysfunction (23.1% vs 5.1%, P = 0.008) and higher LVEF (58.6% vs 53.6%, P = 0.03). OSA was more prevalent in men (27.8% vs 10.3%, P = 0.03). Women had more hypertension (71.8% vs 60.8%) and diabetes (20.5% vs 15.2%), while men had more CAD (15.2% vs 7.7%), and CKD (11.4% vs 5.1%). None of these latter differences were significant.
LA size was significantly larger in blacks as compared to their white counterparts (P = 0.03). Syncope was also more common in blacks (16.7% vs. 2.2%, P = 0.03). There were no other significant baseline differences between blacks and whites, but black patients had older age at time of procedure (65. 4 and late period is demonstrated in Figure 1 (A). There were also no statistical differences in rates of early and late recurrences within gender groups.
Recurrence of AF by race
As summarized in Figure 1( 
Recurrence of AF by gender-and race-specific analysis
Combined race-and gender-specific recurrence of AF is presented in Figure 1 (C). The study cohort included 64 white men, 10 black men, 29 white women, and eight black women. Black women had higher rates of CKD compared to white women (25% vs 0%, P = 0.04) and white men had a lower rate of diabetes compared to black men (13% F I G U R E 1 (A) Early and late recurrence among the overall study cohort and then separated by gender. (B) Early and late recurrence among white and black patients. (C) Early and late recurrence by gender-specific ethnicity vs 40%, P = 0.05). Early recurrence was as follows: white men 36%, black men 30%, white women 48%, and black women 38%. Late recurrence was as follows: white men 36%, black men 40%, white women 31%, and black women 25%. White women had the highest rate of early recurrence of AF but differences were not statistically significant. Late recurrence was comparable among the groups.
Predictors of early recurrence
In univariate analysis, CAD was associated with early recurrence in the overall cohort (P = 0.008) and in men (P = 0.01), while thyroid disease (P = 0.03) was associated with early recurrence in women. CAD was associated with early recurrence in white patients (P = 0.003) as well. In multivariate analysis, LA size (odds ratio [OR] = 1.13, 95% confidence interval [CI]: 1.01-1.27, P = 0.04) was predictive in men while age (OR = 1.03, 95% CI: 1.00-1.05, P = 0.02), CAD (OR = 1.67, 95% CI:
1.13-2.47, P = 0.02), and CKD (OR = 2.25, 95% CI: 1.14-4.44, P = 0.03)
were predictive in women. Subgroup analysis showed no significant predictors of AF recurrence in black patients in either univariate or multivariate analysis.
Predictors of late recurrence
With respect to late recurrence, LA size (P = 0.01) and having early recurrence (P < 0.001) were univariate predictors in the overall cohort. Early recurrence also emerged as a univariate predictor in men (P < 0.001) and white (P < 0.001) patients but not in women or blacks.
Additionally, LA size (P = 0.02) was a predictor in white patients. Table 2 demonstrates the multivariate predictors of late recurrence among the entire cohort and gender subgroups. Multivariate analysis demon- 
DISCUSSION
This study investigated the overall impact of ethnicity and gender on the efficacy of CA for AF. The main finding in our cohort is that race and gender differences do not adversely impact the clinical outcomes of CA for AF. Despite blacks having more comorbidities and larger LA size at baseline, CA was similarly effective in maintaining sinus rhythm.
Additionally, early recurrence of AF after CA was not predictive of late recurrence of AF in women but was in men.
In our cohort, single CA showed efficacy in preventing recurrence of AF in all patients with paroxysmal and persistent AF during average 18 months follow-up. Notably, this rate was similar between blacks and whites even as black patients had more underlying comorbidity as potential triggers of AF recurrence, including enlarged LA, hypertension, diabetes, CKD, and lower ejection fraction. Given LA size was a predictor of late recurrence in the overall cohort, it is notable that blacks still had similar ablation outcomes. This indicates that black patients with normal and mildly increased LA size might have had lower recurrence than comparable white patients. At moderate and severely increased LA size, recurrence rates were comparable between ethnicities. These results would be consistent with what is already known about the racial prevalence of AF, namely, that blacks generally have lower rates of AF despite having high rates of traditional risk factors. 7, 9 The two variables, LA size and early recurrence of AF, were most strongly associated with late recurrence in this study group. This finding is consistent with previous report as both factors have been shown to affect AF ablation outcome. 23, 24 The effect of LA size on recurrence of AF was more prominent in women than in the overall cohort. LA size was not an independent predictor for late recurrence in black patients based on multivariate analysis in our cohort. This finding was likely due to the higher prevalence of severe LA dilation in the small sample size of black patients. It is also known that a substantial proportion of patients with early recurrence have long-term maintenance of sinus rhythm. 25, 26 In our cohort, both white and black women had an early recurrence rate that was higher than the late recurrence rate.
Early recurrence was predictive of late recurrence in men but not in women. More generally, gender was shown to have a significant interaction with early recurrence.
It has previously been suggested that early recurrences in women may involve nonpulmonary vein triggers. 25, 27 The results of this study While the role of early recurrence of AF following CA in predicting long-term outcomes has been shown broadly, data regarding gender dependence is not readily apparent. Previous studies have shown early recurrence to be strongly associated with lower long-term success rate, but also that a significant proportion of patients with early recurrence will have no further AF episodes. 25 The presence of structural heart disease and lack of successful anatomic ablation of all targeted pulmonary veins were shown to be independent predictors of early recurrence. 30 Other factors such as age, hypertension, duration of AF, and persistent-permanent AF have also been linked to early recurrence. 31 Our study shows that not only do clinical factors such as CAD and CKD remain important considerations, gender also has a strong impact on the long-term significance of early recurrences.
Recently published studies continue to show different results regarding the efficacy of CA by gender. Our study results are similar to work by Singh et al. that evaluated the 1-year efficacy of initial CA in patients undergoing treatment for persistent AF. Despite women being older than men in the study, single procedure drug-free atrial arrhythmia recurrence occurred in 53% of the cohort with no difference between men and women (54% vs. 53%, P = 1.0). 19 In contrast, Zylla et al. performed a large-scale retrospective study showing that at 1 year women may have higher AF recurrence rates (women 50% vs men 45%, P = 0.017) 20 after CA. Women were also older at the time of ablation and exhibited a higher prevalence of paroxysmal AF in the study. Neither of the two studies compares early and late recurrence rates such as in our study. Overall, this shows the need for large, prospective trials to further study the factors that affect outcomes of CA in women. 33 This indicates that barriers persist with regards to increased utilization of invasive procedures in women.
There are several limitations to this study. This was a single-center study performed at a tertiary care academic center. Patients referred to our institution may be more likely to be sicker with refractory disease and to have more comorbidities. Although prior failed therapies
were not specifically tracked in this study, only patients who were undergoing first-time CA were included. This was done in an effort to maintain a more uniform cohort of patients. There were also limitations in regards to monitoring of patients postprocedure for AF recurrence. Because patients generally did not have continuous longterm outpatient monitoring, asymptomatic or brief recurrences would have been missed across the cohort. Previously published work, however, has shown that continuous monitoring in patients deemed AFfree at greater than 1 year identifies only a small number of additional recurrences. 34 Lastly, there were a relatively small number of black patients in our study cohort, limiting our ability to determine significant predictors of recurrence.
CONCLUSION
Our study demonstrated no disparity regarding the long-term efficacy of CA between men and women, or between black and white patients.
CA should be offered to appropriate patients regardless of gender or race. Further work to determine which factors are more predictive of success after CA in specific races and between genders would expand on our findings.
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